Two children die of measles in England: the vaccination-rate question behind 100 new cases

According to weekly data released by the UK Health Security Agency, UKHSA, two children have died from complications of measles, and more than 100 new cases have been recorded in recent weeks. As Guardian Health reported, this wave is once again exposing the long-standing fragility of the country's MMR vaccination coverage.
What is measles and why can it still be fatal? Measles is a highly contagious disease caused by an RNA virus in the Paramyxoviridae family. When an unvaccinated child is exposed to the virus, on average 12 to 18 other people can become infected — that is, the basic reproduction number R0 sits between 12 and 18. Complications include pneumonia, encephalitis, deafness and, rarely, subacute sclerosing panencephalitis (SSPE).
According to the Guardian report, the new cases are concentrated in north-east London, Manchester and parts of Birmingham. UKHSA data show MMR coverage in those areas ranges between 75 and 82 per cent — well below the 95 per cent threshold the World Health Organization recommends for community immunity.
Why has vaccination coverage fallen? Several factors combine. Delays in routine childhood vaccination appointments during the pandemic, the spread of anti-vaccine misinformation on social media, difficulty accessing NHS GP appointments and historical mistrust of vaccination in some communities are at the top of the list. UKHSA says misinformation "spreads on social platforms about six times faster than official information."
The basis of measles vaccination is the MMR combination — measles, mumps and rubella. Once the two-dose series is complete, the vaccine offers around 97 per cent protection that may last for life. Billions of doses have been administered worldwide and serious side effects remain extremely rare. The discredited MMR-autism link rested on Andrew Wakefield's 1998 paper, which was retracted from the academic journal that published it; Wakefield himself lost his medical licence.
This wave is not unique to England. As the Guardian reports, measles cases in the United States this year have reached their highest levels since the 2000s, with clusters in Texas, New Mexico and Florida. In Europe, large outbreaks have hit Romania and Bulgaria. In Türkiye the Ministry of Health has recorded a rise in cases during 2024-2025 and has begun studies to re-evaluate the age of MMR administration and the timing of booster doses.
UKHSA's urgent advice is clear. Parents of children under five are being asked to make sure that their child has completed two doses of MMR. If doses are missing, a GP appointment to catch up is important; many practices now commit to offering vaccination appointments in early morning and late evening slots. UKHSA chief Professor Dame Jenny Harries told the Guardian, "No child should die of a preventable disease."
For adults, the picture is slightly different. Those born between 1970 and 1980 may have been exposed to measles in childhood before MMR existed and may carry natural immunity; but a blood test or two doses of MMR are enough to be sure. Health workers, women planning pregnancy and travellers should always check.
Public-health specialists also say the reported case count may be an undercount. Because the early symptoms of measles are flu-like, mild cases can go undiagnosed; the true case count is estimated to be five to ten times the recorded figure. That is why every family checking its MMR status carries not only an individual but a community responsibility.
The practical take-away for Vesper readers is that measles is a preventable disease and that vaccination above 95 per cent community coverage breaks the chain of individual transmission. Spending a few minutes to check your child's vaccination card, to book a GP appointment or to verify your status before travel stands out as the most effective way to break the next link in this summer's outbreak.
Read next

Glucosamine and Alzheimer's: what a popular joint supplement may mean for the brain
New research suggests that glucosamine, a widely used joint supplement, may speed up the progression of Alzheimer's disease in patients who already have dementia. Science Daily explains what the findings mean for all users and who falls into the at-risk group.

The strength training sweet spot for a longer life: how many minutes a week are enough
Scientists have identified a "sweet spot" at which strength training reduces the risk of death. According to the study reported by Science Daily, a particular weekly minute range delivers better outcomes than doing less or more; the ideal duration, frequency and set count are explained.

What is synthetic lethality? The principle that is rekindling cancer drug research
Synthetic lethality is the principle by which inhibiting a second target proves fatal to a cancer cell when a first gene has been lost. STAT News reports on how the principle is fuelling a new wave of biotech mergers and acquisitions and which companies are appearing on investors' radars.

Meningitis B vaccine: why a million young people in the UK are being offered the shot
England will offer the meningitis B vaccine to around a million young people, including school leavers and university students. BBC Health set out why the programme is being launched, which age group is most at risk and what level of protection the shot provides.

Lupus and CAR-T cell therapy: how an immune reset is putting patients into remission
Lupus is a chronic disease in which the immune system attacks the body's own tissue. A new cell therapy reprograms patients' own T-cells and, in some cases, has produced drug-free remission; BBC Health reported the findings of a new UK trial.
